These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28425797)

  • 21. Antihypertensive efficacy of candesartan in comparison to losartan: the CLAIM study.
    Bakris G; Gradman A; Reif M; Wofford M; Munger M; Harris S; Vendetti J; Michelson EL; Wang R;
    J Clin Hypertens (Greenwich); 2001; 3(1):16-21. PubMed ID: 11416677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension.
    Himmelmann A; Keinänen-Kiukaanniemi S; Wester A; Redón J; Asmar R; Hedner T;
    Blood Press; 2001; 10(1):43-51. PubMed ID: 11332334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Achieving Quality 24-h Blood Pressure Control with Candesartan Cilexetil.
    Meredith P
    Blood Press; 2000; 9(sup1):23-26. PubMed ID: 28425796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amlodipine Besylate versus Candesartan Cilexetil in Hypertensive Patients - Office and Self-Measured Blood Pressure : A Randomised, Double-Blind, Comparative, Multicentre Trial.
    Trenkwalder P; Regourd E; Kluth-Pepper B; Sauerbrey-Wullkopf N
    Clin Drug Investig; 2005; 25(9):567-77. PubMed ID: 17532701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators.
    Reif M; White WB; Fagan TC; Oparil S; Flanagan TL; Edwards DT; Cushing DJ; Michelson EL
    Am J Cardiol; 1998 Oct; 82(8):961-5. PubMed ID: 9794352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Switch from ABCD pretreatment to A-II-A treatment: a multinational, open, centrally randomized, prospective parallel group comparison.
    Asmar R; Porcellati C; Dusing R
    Drugs Exp Clin Res; 2004; 30(4):153-61. PubMed ID: 15553661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of angiotensin II receptor blockers: impact of missed doses of candesartan cilexetil and losartan in systemic hypertension.
    Mancia G; Dell'Oro R; Turri C; Grassi G
    Am J Cardiol; 1999 Nov; 84(10A):28S-34S. PubMed ID: 10588092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers.
    Hübner R; Högemann AM; Sunzel M; Riddell JG
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S19-25. PubMed ID: 9331000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Achieving quality 24-h blood pressure control with candesartan cilexetil.
    Meredith P
    Blood Press Suppl; 2000; 1():23-6. PubMed ID: 11059632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan.
    Azizi M; Chatellier G; Guyene TT; Ménard J
    J Hypertens; 1999 Apr; 17(4):561-8. PubMed ID: 10404959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive population.
    McInnes GT; O'Kane KP; Jonker J; Roth J
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S75-80. PubMed ID: 9331015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candesartan Cilexetil is not Associated with Cough in Patients with Enalapril-induced Cough.
    Tanser P; Campbell LM; Carranza J; Karrasch J; Toutouzas P; Watts R
    Blood Press; 2000; 9(sup1):56. PubMed ID: 28425800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of angiotensin II receptor blockers alone and in combination with other drugs: a large clinical experience trial.
    Weir MR; Wang RY
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1_suppl):S217-S222. PubMed ID: 28095219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerability of a modern antihypertensive agent: candesartan cilexetil.
    Andersson OK
    Basic Res Cardiol; 1998; 93 Suppl 2():54-8. PubMed ID: 9833164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil assessed by 24-hour ambulatory blood pressure monitoring in patients with essential hypertension.
    Brunner HR; Stumpe KO; Januszewicz A
    Clin Drug Investig; 2003; 23(7):419-30. PubMed ID: 17535053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candesartan cilexetil: in children and adolescents aged 1 to <17 years with hypertension.
    Hoy SM; Keating GM
    Am J Cardiovasc Drugs; 2010; 10(5):335-42. PubMed ID: 20860416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is it Possible to Differentiate between Angiotensin II Type 1 (AT1) Receptor Blockers in Normotensive Volunteers?
    Azizi M; Chatellier G; Nicolet L; Guyene T; Hempenius J; Ménard J
    Blood Press; 2000; 9(sup1):53. PubMed ID: 28425793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newly emerging pharmacologic differences in angiotensin II receptor blockers.
    Oparil S
    Am J Hypertens; 2000 Jan; 13(1 Pt 2):18S-24S. PubMed ID: 10678284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.